Hyphens Pharma International Limited (SGX:1J5)

SGXC:1J5 Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	23.33	26.83	23.42	23.37	36.48	19.46
Cash & Short-Term Investments	23.33	26.83	23.42	23.37	36.48	19.46
Cash Growth	24.20%	14.58%	0.22%	-35.94%	87.45%	-29.30%
Accounts Receivable	32.02	33.15	43.16	39.63	30.12	27.82
Other Receivables	1.26	1.1	1.56	0.75	0.39	0.3
Receivables	33.29	34.25	44.71	40.38	30.51	28.12
Inventory	28.19	29.34	34.45	25.53	21.26	25.29
Prepaid Expenses	5.96	4.44	2.53	2.06	0.81	0.64
Other Current Assets	0.69	0.74	0.98	0.82	0.59	0.6
Total Current Assets	91.46	95.6	106.09	92.15	89.65	74.11
Property, Plant & Equipment	6.49	3.87	4.9	4.86	3.02	4.41
Long-Term Investments	-	-	-	-	2.67	2.31
Goodwill	15.4	15.4	15.4	15.4	12.81	12.81
Other Intangible Assets	8.2	8.59	9.13	8.18	6.26	5.49
Long-Term Deferred Tax Assets	0.11	0.15	0.23	0.17	0.06	0.07
Total Assets	121.65	123.6	135.75	120.77	114.47	99.19

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	39.71	36.44	42.3	42.83	34.19	32.42
Short-Term Debt	-	3.8	9.01	-	-	4.24
Current Portion of Long-Term Debt	5.23	1.1	1.25	1.25	1.25	1.83
Current Portion of Leases	1.26	1.42	1.28	1.17	1.09	1.21
Current Income Taxes Payable	2.92	2.18	2.58	2.54	2.66	1.71
Other Current Liabilities	-	2.13	1.27	1.46	0.88	1.15
Total Current Liabilities	49.12	47.07	57.69	49.24	40.07	42.56
Long-Term Debt	1.88	2.63	0.73	1.98	3.23	-
Long-Term Leases	2.79	0.48	1.84	2.43	0.1	0.88
Long-Term Deferred Tax Liabilities	0.79	0.85	1.02	1.25	0.79	1.02
Total Liabilities	54.58	51.03	61.28	54.9	44.2	44.46

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	35.22	35.22	35.22	35.22	35.08	35.08
Retained Earnings	39.19	43.5	45.23	37.77	43.76	34.61
Treasury Stock	-0.08	-0.09	-0.09	-	-	-
Comprehensive Income & Other	-8.14	-8.57	-9.46	-10	-9.82	-14.96
Total Common Equity	66.19	70.06	70.9	62.99	69.03	54.74
Minority Interest	0.89	2.51	3.57	2.88	1.25	-
Shareholders' Equity	67.07	72.57	74.47	65.86	70.27	54.74
Total Liabilities & Equity	121.65	123.6	135.75	120.77	114.47	99.19

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	11.16	9.43	14.11	6.82	5.67	8.17
Net Cash (Debt)	12.18	17.41	9.31	16.55	30.81	11.29
Net Cash Growth	72.72%	87.04%	-43.76%	-46.29%	172.85%	-49.93%
Net Cash Per Share	0.04	0.06	0.03	0.05	0.10	0.04
Filing Date Shares Outstanding	308.91	308.87	308.88	309.2	308.78	308.78
Total Common Shares Outstanding	308.91	308.87	308.88	309.2	308.78	308.78
Working Capital	42.34	48.52	48.4	42.91	49.58	31.56
Book Value Per Share	0.21	0.23	0.23	0.20	0.22	0.18
Tangible Book Value	42.59	46.07	46.37	39.41	49.96	36.44
Tangible Book Value Per Share	0.14	0.15	0.15	0.13	0.16	0.12
Machinery	13.6	9.83	11.99	10.64	10.81	10.28

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 25, 2026

Data Sources Report a data error